M-A: Association of immune checkpoint inhibitors with neurologic adverse events.

Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis – JAMA Network Open

Invited Commentary: Neurological Toxic Effects Associated With Treatment With Immune Checkpoint Inhibitors—Are We Really Safer Now? – JAMA Network Open

Related:

Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review – Neurology (link to abstract – $ for full-text)

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system – Therapeutic Advances in Neurologic Disorders

Commentary on Twitter

Meta-analysis of 39 RCTs found immune checkpoint inhibitors have lower risk of neurological adverse effects compared to cytotoxic chemotherapy, but higher than placebo, across a range of malignancies. https://t.co/02GhICcu5H

— JAMA Network Open (@JAMANetworkOpen) April 19, 2022